Literature DB >> 8788567

Innervation of cerebral arteries by nerves containing 5-hydroxytryptamine and noradrenaline.

J Lincoln1.   

Abstract

Noradrenaline (NA)-containing nerves, mainly originating in the sympathetic superior cervical ganglia, supply large and small cerebral arteries. In large cerebral arteries, nerves containing serotonin (5-hydroxytryptamine, 5-HT) may represent neuronal uptake of circulating 5-HT by sympathetic nerves. 5-HT-containing nerves supplying small pial vessels probably have a central origin in the dorsal raphe nucleus. In most species, NA is a weak vasoconstrictor (alpha 1- or alpha 2-adrenoceptors), while 5-HT is a potent vasoconstrictor (5-HT2 or 5-HT1-like receptors) of large cerebral arteries. In contrast, both NA and 5-HT tend to cause vasodilatation in small pial vessels and arterioles. Adrenergic and serotonergic transmission can be modulated by pH, a range of putative neurotransmitters and neuromodulators, and by the endothelium. Sumatriptan, a 5-HT1-like receptor agonist, has been shown to be effective in the treatment of migraine. Changes in NA- or 5-HT-containing nerves and/or in the responses of cerebral vessels to NA and 5-HT have been observed in a variety of vascular disorders, including cerebral vasospasm following subarachnoid haemorrhage, hypertension, and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788567     DOI: 10.1016/0163-7258(95)02017-9

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  21 in total

1.  Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease.

Authors:  Sarah C Kelly; Erin C McKay; John S Beck; Timothy J Collier; Anne M Dorrance; Scott E Counts
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles.

Authors:  A Elhusseiny; E Hamel
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Severe Cerebral Vasospasm in Patients with Hyperthyroidism.

Authors:  Hyuk-Jin Oh; Seok-Mann Yoon; Jae-Sang Oh; Jai-Joon Shim; Hack-Gun Bae
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-12-31

Review 4.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

5.  The effects of different aerobic exercise intensities on serum serotonin concentrations and their association with Stroop task performance: a randomized controlled trial.

Authors:  Philipp Zimmer; Christian Stritt; Wilhelm Bloch; Frank-Peter Schmidt; Sven Thorsten Hübner; Stephan Binnebößel; Alexander Schenk; Max Oberste
Journal:  Eur J Appl Physiol       Date:  2016-08-25       Impact factor: 3.078

6.  Inflow of oxygen and glucose in brain tissue induced by intravenous norepinephrine: relationships with central metabolic and peripheral vascular responses.

Authors:  R Aaron Bola; Eugene A Kiyatkin
Journal:  J Neurophysiol       Date:  2017-11-08       Impact factor: 2.714

7.  Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor.

Authors:  Paulo W Pires; William F Jackson; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

Review 8.  The effects of hypertension on the cerebral circulation.

Authors:  Paulo W Pires; Carla M Dams Ramos; Nusrat Matin; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

9.  The effect of ovariectomy and estrogen on penetrating brain arterioles and blood-brain barrier permeability.

Authors:  Marilyn J Cipolla; Julie A Godfrey; Marchien J Wiegman
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

10.  Dilatation induced by 5-HT in the middle meningeal artery of the anaesthetised cat.

Authors:  Geoffrey Andrew Lambert; Cathy Donaldson; Karen Lisa Hoskin; Peter Michael Boers; Alessandro Stefano Zagami
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.